股本结构

单位:万股
公告日期 2025-12-12 2025-11-17 2025-11-17 2025-08-14 2025-07-31 2025-08-14
证券总股本 293.87 285.31 276.42 270.87 276.42 76.42
普通股本 293.87 285.31 276.42 270.87 276.42 76.42
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2025-12-01 2025-11-14 2025-09-30 2025-08-12 2025-07-31 2025-06-30
注释:中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本(万股) 变动后优先股(万股) 变动原因 变动日期
2025-12-12 293.87 未披露 定期报告 2025-12-01
2025-11-17 285.31 未披露 定期报告 2025-11-14
2025-11-17 276.42 未披露
更多>>
From June 30, 2025 to September 30, 2025 Common stock and warrant issuance, net of costs
2025-09-30
2025-08-14 270.87 未披露 定期报告 2025-08-12
2025-07-31 276.42 未披露
更多>>
Common stock offered 2,000,000 shares by the company
2025-07-31
2025-08-14 76.42 未披露
更多>>
From March 31, 2025 to June 30, 2025 Common stock issuance, net of costs Adjustment for fractional shares
2025-06-30
2025-07-15 76.42 未披露 定期报告 2025-06-23
2025-03-27 7229.00 未披露 定期报告 2025-03-24
2025-02-03 6875.43 未披露 定期报告 2025-01-31
2025-01-23 6766.83 未披露 定期报告 2025-01-22
2025-03-27 6552.63 未披露
更多>>
From December 31, 2023 to December 31, 2024 Equity-based compensation Issuance of warrants Repayment of Debt with Shares Common stock issuance, net of costs Cashless exercise of warrants
2024-12-31
2024-12-04 6377.93 未披露 定期报告 2024-12-02
2024-11-15 6370.64 未披露 定期报告 2024-11-13
2024-11-04 6370.64 未披露 定期报告 2024-10-28
2024-10-01 6332.17 未披露
更多>>
Securities offered 4,653,036 shares by the company
2024-10-01
2024-11-14 5866.86 未披露
更多>>
From June 30, 2024 to September 30, 2024 Common stock issuance, net of costs Equity-based compensation
2024-09-30
2024-07-25 5713.67 未披露 定期报告 2024-07-24
2024-08-14 5713.67 未披露
更多>>
From March 31, 2024 to June 30, 2024 Common stock issuance, net of costs Series B preferred shares expired
2024-06-30
2024-06-03 5713.67 未披露
更多>>
Common stock offered 5,640,958 shares by the company
2024-06-03
2024-06-03 5149.57 未披露 定期报告 2024-05-30
2024-05-15 5128.14 未披露 定期报告 2024-05-13
2024-05-01 5088.83 未披露 定期报告 2024-04-26
2024-05-15 5025.19 0.07
更多>>
From December 31, 2023 to March 31, 2024 Common Stock issuance, net of costs Cashless Exercise of Warrants Committed Shares
2024-03-31
2024-04-01 4990.12 未披露 定期报告 2024-03-27
2024-04-01 4910.25 0.07
更多>>
From December 31, 2022 to December 31, 2023 Common stock issuance, net of costs Series B preferred shares converted to common shares
2023-12-31
2023-11-14 4884.17 未披露 定期报告 2023-11-12
2023-11-01 4879.76 未披露 定期报告 2023-10-02
2023-11-14 4879.75 0.07
更多>>
From June 30, 2023 to September 30, 2023 Common stock issuance, net of costs
2023-09-30
2023-08-14 4867.04 未披露 定期报告 2023-08-11
2023-08-14 4841.95 0.07
更多>>
From March 31, 2023 to June 30, 2023 Common stock issuance, net of costs Series B preferred shares converted to common shares
2023-06-30
2023-05-15 4840.83 未披露 定期报告 2023-05-10
2023-05-15 4840.73 0.07
更多>>
From December 31, 2022 to March 31, 2023 Common Stock issuance, net of costs Series B preferred shares converted to common
2023-03-31
2023-03-31 4840.73 未披露 定期报告 2023-03-28
2023-03-31 4808.43 0.07
更多>>
From December 31, 2021 to December 31, 2022 Common Stock issuance, net of costs Warrant modification
2022-12-31
2022-11-14 4808.23 0.07
更多>>
From June 30, 2022 to September 30, 2022 Common stock issuance, net of costs Cashless Warrant Conversion
2022-09-30
2022-08-15 4804.93 0.07 定期报告 2022-08-11
2022-08-15 4804.88 0.07
更多>>
From March 31, 2022 to June 30, 2022 Series B preferred shares converted to common shares Common stock issuance, net of costs
2022-06-30
2022-05-13 4804.88 未披露 定期报告 2022-05-10
2022-05-13 4799.47 0.07 定期报告 2022-03-31
2022-03-31 4799.47 未披露 定期报告 2022-03-25
2022-01-21 4649.66 0.07 定期报告 2022-01-19
2022-03-31 4799.47 0.07
更多>>
From December 31, 2020 to December 31, 2021 Series B preferred shares converted to Common shares Shares issued for: Common Stock issuance, net of costs Shares issued to pay accounts payable
2021-12-31
2021-11-15 4784.86 0.07
更多>>
From June 30, 2021 to September 30, 2021 Common stock issuances, net of costs
2021-09-30
2021-08-16 4784.86 未披露 定期报告 2021-08-11
2021-05-17 4783.30 0.07
更多>>
From December 31, 2020 To March 31, 2021 Series B preferred shares converted to common shares Common stock issuances, net of costs
2021-03-31
2021-03-31 4782.19 未披露 定期报告 2021-03-26
2021-03-31 4215.44 0.07
更多>>
from December 31, 2019 to December 31, 2020 Common Stock issuance, net of costs Shares issued to pay accounts payable Series B preferred shares converted to Common shares
2020-12-31
2020-11-12 4068.65 未披露 定期报告 2020-11-11
2020-11-12 4068.53 0.07
更多>>
From December 31, 2019 to September 30, 2020 Common stock issuances Shares issued to pay accounts payable Series B preferred shares converted to common shares
2020-09-30
2020-08-14 3969.00 未披露 定期报告 2020-08-13
2020-08-11 3969.10 未披露 定期报告 2020-08-10
2020-08-14 3425.06 0.07
更多>>
From December 31, 2019 to June 30, 2020 Series B preferred shares converted to common shares Shares issued for: Common stock issuances
2020-06-30
2020-06-15 3262.42 未披露 定期报告 2020-06-12
2020-05-14 2918.65 未披露 定期报告 2020-05-10
2020-05-14 2805.05 0.08
更多>>
From December 31, 2019 to March 31, 2020 Series B preferred shares converted to common shares Shares issued for: Common stock issuances Shares issues to pay account payable
2020-03-31
2020-03-30 2762.61 未披露 定期报告 2020-03-27
2020-03-30 1038.68 0.08
更多>>
From December 31, 2018 to December 31, 2019 Series B preferred shares issued, net of offering costs Series B preferred shares converted to Common shares Shares issued for: Shares sold at the market Common Stock issuance, net of costs Convertible note origination shares Equity-based compensation Shares issues to pay accounts payable
2019-12-31
2019-11-14 826.40 未披露 定期报告 2019-11-12
2019-11-14 609.73 未披露
更多>>
From June 30, 2019 to September 30, 2019 Equity-based compensation Common stock issuance, net of costs Convertible debt Shares issued to pay accounts payable Series B preferred shares converted to common shares
2019-09-30
2019-09-27 483.92 未披露 定期报告 2019-09-27
2019-09-24 309.86 未披露 定期报告 2019-09-23
2019-08-20 244.20 未披露 定期报告 2019-08-19
2019-08-14 230.70 未披露 定期报告 2019-08-01
2019-07-22 221.70 未披露 定期报告 2019-07-18
2019-08-14 221.49 未披露
更多>>
From December 31, 2018 to June 30, 2019 Equity-based compensation Common stock issuance, net of offering costs Convertible debt Shares issued to pay accounts payable Series B preferred shares converted to common shares
2019-06-30
2019-06-05 220.06 未披露
更多>>
As previously disclosed, following stockholder approval of a reverse stock split, the Company’s Board of Directors approved a 1-for-44 reverse stock split of the Company’s issued and outstanding shares of common stock. The Company anticipates that the reverse stock split will be effected on June 10, 2019, and the Company’s common stock will begin trading on a split-adjusted basis on June 11, 2019. The reverse stock split will reduce the number of shares of the Company’s common stock currently outstanding from approximately 96,827,062 shares to approximately 2,200,616 shares.
2019-06-11
2019-05-15 8662.13 未披露 定期报告 2019-05-06
2019-04-24 6810.40 未披露 定期报告 2019-04-18
2019-05-15 6290.03 未披露
更多>>
From December 31, 2018 to March 31, 2019 Common stock issuance, net of costs Series B preferred shares issued, net of costs Series B preferred shares converted to common shares
2019-03-31
2019-04-01 6229.03 未披露 定期报告 2019-03-22
2019-02-06 4891.19 未披露 定期报告 2019-02-05
2019-04-01 4873.47 未披露
更多>>
From December 31, 2017 to December 31, 2018 Shares sold at the market Common stock issuance, net of costs Convertible note origination shares Other issuance Equity-based compensation
2018-12-31
2018-12-27 4873.47 未披露 定期报告 2018-12-21
2018-11-14 4818.96 未披露 定期报告 2018-11-01
2018-11-14 4795.79 未披露
更多>>
From December 31, 2017 to September 30, 2018 Equity-based compensation Common stock issuance, net of costs Common stock issued to settle accounts payable Convertible note origination shares
2018-09-30
2018-08-14 4724.68 未披露 定期报告 2018-08-07
2018-08-03 4721.05 未披露 定期报告 2018-08-01
2018-07-20 4687.26 未披露 定期报告 2018-07-18
2018-08-14 4681.80 未披露
更多>>
From December 31, 2017 to June 30, 2018 Equity-based compensation Common stock issuance, net of costs Common stock issued to settle accounts payable
2018-06-30
2018-07-02 4675.80 未披露 定期报告 2018-06-25
2018-05-15 4620.30 未披露 定期报告 2018-05-01
2018-05-15 3921.94 未披露
更多>>
From December 31, 2017 to March 31, 2018 Equity-based compensation Common stock issuance, net of costs Common stock issued to settle accounts payable
2018-03-31
2018-03-30 3771.52 未披露 定期报告 2018-03-26
2018-03-30 3288.48 未披露
更多>>
from December 31, 2016 to December 31, 2017 Shares issued for: Shares sold at the market Common stock issuance Other issuance Equity-based compensation
2017-12-31
2017-11-14 3176.12 未披露 定期报告 2017-11-01
2017-11-14 3107.74 未披露
更多>>
From December 31, 2016 To September 30, 2017 Equity-based compensation Common stock issuance, net of costs Common stock issued for accounts payable
2017-09-30
2017-09-29 3107.74 未披露 定期报告 2017-09-26
2017-08-14 2916.93 未披露 定期报告 2017-08-01
2017-08-14 2895.77 未披露
更多>>
from December 31, 2016 to June 30, 2017 Equity-based compensation Common stock issuance, net of costs Stock issued for accounts payable
2017-06-30
2017-05-19 2658.91 未披露 定期报告 2017-05-17
2017-05-15 2646.11 未披露 定期报告 2017-05-01
2017-05-15 2618.70 未披露
更多>>
from December 31, 2016 to March 31, 2017 Equity-based compensation Common stock issuance, net of costs Stock issued for accounts payable
2017-03-31
2017-03-31 2618.70 未披露 定期报告 2017-03-10
2017-03-31 2420.29 未披露
更多>>
From December 31, 2015 to December 31, 2016 Shares issued for: Shares sold at the market Common stock issuance Other issuance Equity-based compensation Hemispherx Biopharma, announced today that it will effect a 1-for-12 reverse stock split of its common stock.The Company anticipates that the reverse stock split will be effective on August 26, 2016, and the Company's common stock will begin trading on a split-adjusted basis on August 29, 2016.
2016-12-31
2016-11-14 2410.56 未披露
更多>>
from December 31, 2015 to September 30, 2016 Equity-based compensation Shares sold at the market Common stock issuance Other issuances Hemispherx Biopharma, announced today that it will effect a 1-for-12 reverse stock split of its common stock.The Company anticipates that the reverse stock split will be effective on August 26, 2016, and the Company's common stock will begin trading on a split-adjusted basis on August 29, 2016.
2016-09-30
2016-08-17 2074.44 未披露
更多>>
Hemispherx Biopharma, announced today that it will effect a 1-for-12 reverse stock split of its common stock.The Company anticipates that the reverse stock split will be effective on August 26, 2016, and the Company's common stock will begin trading on a split-adjusted basis on August 29, 2016.
2016-08-29
2016-08-15 24893.22 未披露 定期报告 2016-08-01
2016-08-15 24882.97 未披露
更多>>
from December 31, 2015 to June 30, 2016 Shares sold at the market
2016-06-30
2016-06-27 24866.17 未披露 定期报告 2016-06-20
2016-05-16 24791.85 未披露 定期报告 2016-05-06
2016-05-16 24757.19 未披露
更多>>
from December 31, 2015 to March 31, 2016 Shares sold at the market
2016-03-31
2016-03-29 24757.19 未披露 定期报告 2016-03-28
2016-03-29 24755.95 未披露
更多>>
from December 31, 2014 to December 31, 2015 Shares issued for: Settlement of accounts payable Shares sold at the market
2015-12-31
2015-11-16 24751.70 未披露 定期报告 2015-11-01
2015-11-16 24755.73 未披露
更多>>
from December 31, 2014 to September 30, 2015 Shares to settle accounts payable Shares sold at the market
2015-09-30
2015-08-12 24688.68 未披露 定期报告 2015-08-01
2015-08-12 24548.35 未披露
更多>>
From December 31, 2014 to June 30, 2015 Shares to settle accounts payable Shares sold at the market
2015-06-30
2015-06-25 24255.47 未披露 定期报告 2015-06-01
2015-05-12 23255.88 未披露 定期报告 2015-05-01
2015-05-12 22573.77 未披露
更多>>
from December 31, 2014 to March 31, 2015 Shares sold at the market
2015-03-31
2015-03-19 21509.56 未披露 定期报告 2015-03-01
2015-03-19 20400.48 未披露
更多>>
from December 31, 2013 to December 31, 2014 Stock issued for:settlement of accounts payable Stock issued for:Shares sold at the market
2014-12-31
2014-11-07 20002.79 未披露 定期报告 2014-11-01
2014-10-10 19538.21 未披露 定期报告 2014-10-03
2014-11-07 19370.84 未披露
更多>>
from December 31, 2013 to September 30, 2014 Stock issued for settlement of accounts payable Shares sold at the market
2014-09-30
2014-08-08 18999.75 未披露 定期报告 2014-08-01
2014-08-08 18949.87 未披露
更多>>
from December 31, 2013 to June 30, 2014 Stock issued for settlement of accounts payable Shares sold at the market
2014-06-30
2014-05-09 18385.38 未披露 定期报告 2014-04-25
2014-05-09 18328.52 未披露
更多>>
from December 31, 2013 to March 31, 2014 Stock issued for settlement of accounts payable Shares sold at the market
2014-03-31
2014-03-14 17934.04 未披露 定期报告 2014-03-01
2014-03-14 16866.04 未披露
更多>>
From December 31,2012 to December 31,2013 Settlement of accounts payable Shares sold at the market
2013-12-31
2013-11-08 16768.66 未披露 定期报告 2013-11-01
2013-11-08 16755.20 未披露
更多>>
from December 31, 2012 to September 30, 2013 Stock issued for settlement of accounts payable
2013-09-30
2013-08-09 16739.72 未披露 定期报告 2013-08-01
2013-08-09 16722.99 未披露
更多>>
from December 31, 2012 to May 1, 2013 Stock issued for settlement of accounts payable
2013-05-01
2013-05-13 16707.41 未披露
更多>>
From December 31, 2012 to March 31, 2013 Stock issued for settlement of accounts payable
2013-03-31
2013-03-18 16678.46 未披露 定期报告 2013-03-01
2013-03-18 16649.02 未披露
更多>>
from December 31, 2011 to December 31, 2012 Shares issued for:Settlement of accounts payable Shares issued for:Shares sold at the market Equity-based compensation
2012-12-31
2012-11-02 15101.07 未披露 定期报告 2012-11-01
2012-11-02 14750.85 未披露
更多>>
from December 31, 2011 to September 30, 2012 Shares sold at the market Stock issued for settlement of accounts payable Equity-based compensation
2012-09-30
2012-08-08 13622.10 未披露
更多>>
from December 31, 2011 to June 30, 2012 Stock issued for settlement of accounts payable Equity-based compensation
2012-06-30
2012-06-19 13599.83 未披露 定期报告 2012-06-15
2012-05-07 13595.02 未披露 定期报告 2012-05-01
2012-03-14 13583.20 未披露 定期报告 2012-03-01
2012-03-14 13564.23 未披露
更多>>
from December 31, 2010 to December 31, 2011 Shares issued for:Settlement of accounts payable and accrued expenses Stock-based compensation
2011-12-31
2011-11-09 13556.65 未披露 定期报告 2011-11-01
2011-11-09 13524.16 未披露
更多>>
from December 31, 2010 to September 30, 2011 Stock issued for settlement of accounts payable Equity based compensation
2011-09-30
2011-08-05 13548.20 未披露 定期报告 2011-08-01
2011-08-05 13545.89 未披露
更多>>
from December 31, 2010 to June 30, 2011 Stock issued for settlement of accounts payable Equity based compensation
2011-06-30
2011-05-06 13533.58 未披露
更多>>
Stock issued for settlement of accounts payable
2011-03-31
2011-03-29 13524.16 未披露
更多>>
from December 31, 2009 to December 31, 2010 Shares issued for:Settlement of accounts payable Shares issued for:Shares sold at the market Stock based compensation
2010-12-31
2010-11-08 13524.16 未披露
更多>>
from December 31, 2009 to September 30, 2010 Stock issued for settlement of accounts payable Equity based compensation Shares sold at the market
2010-09-30
2010-08-06 13439.64 未披露 定期报告 2010-08-03
2010-08-06 13436.87 未披露
更多>>
from December 31, 2009 to June 30, 2010 Stock issued for settlement of accounts payable Equity based compensation Shares sold at the market
2010-06-30
2010-05-07 13287.69 未披露 定期报告 2010-05-05
2010-05-07 13286.06 未披露
更多>>
Stock issued for settlement of accounts payable
2010-03-31
2010-03-12 13284.10 未披露 定期报告 2010-03-01
2010-03-12 13278.74 未披露
更多>>
from December 31, 2008 to December 31, 2009 Shares issued for:Warrants exercised Shares issued for:Options exercised Shares issued for:Private placement, net of issuance costs Shares issued for:Settlement of accounts payable Stock based compensation
2009-12-31
2009-03-16 8088.11 未披露 定期报告 2009-03-03
2009-03-16 7875.10 未披露
更多>>
from December 31, 2007 to December 31, 2008 Shares issued for:Private placement, net of issuance costs Shares issued for:Settlement of accounts payable
2008-12-31
2008-03-17 7388.61 未披露 定期报告 2008-03-03
2008-03-17 7376.04 未披露
更多>>
from December 31, 2006 to December 31, 2007 Shares issued for:Interest on convertible debt Shares issued for:Private placement, net of issuance costs Shares issued for:Stock issued for settlement of accounts payable
2007-12-31
2007-03-19 6964.00 未披露 定期报告 2007-03-08
2007-03-19 6681.68 未披露
更多>>
from December 31, 2005 to December 31, 2006 Shares issued for:Payment of accounts payable Shares issued for:Conversion of debt Shares issued for:Warrants exercised Shares issued for:Interest in convertible debt Shares issued for:Private placement, net of issuance costs Shares issued for:Purchase patents Shares issued for:Purchase royalty interest
2006-12-31
2006-04-03 6108.36 未披露 定期报告 2006-03-24
2006-04-03 5626.42 未披露
更多>>
from December 31, 2004 to December 31, 2005 Payment of accounts payable Conversion of debt Interest on convertible debt Private placement, net of issuance costs
2005-12-31
2005-03-16 4984.93 未披露 定期报告 2005-03-11
2005-03-16 4963.18 未披露
更多>>
from December 31, 2003 to December 31, 2004 Shares issued for:Payment of accounts payable Shares issued for:OID on convertible debt Shares issued for:Purchase of building Shares issued for:Conversion of debt Shares issued for:Interest on convertible debt Shares issued for:Private placement, net of issuance costs Shares issued for:Warrants exercised Stock Issued with convertible debt Treasury shares sold
2004-12-31
2004-03-12 4083.52 未披露 定期报告 2004-02-27
2004-03-12 3906.71 未披露
更多>>
from December 31, 2002 to December 31, 2003 Debt conversion and interest payments Warrants exercised Common stock issued in connection with ISI acquisition Treasury Stock retired Conversion of minority interest of subsidiary into common stock Stock issued in settlement of debt Treasury stock purchased
2003-12-31
2003-04-15 3294.14 未披露 定期报告 2003-03-31
2003-04-15 3210.70 未披露
更多>>
from December 31,2001 to December 31,2002 Stock issued in settlement of debt Treasury stock Purchased
2002-12-31
2002-04-09 3206.03 未披露
更多>>
from December 31, 2000 to December 31, 2001 Common stock issued Purchase of equity investment Stock issued in settlement of debt Stock and stock warrant compensation expense Treasury stock purchased
2001-12-31
2001-04-03 2997.22 未披露
更多>>
from December 31, 1999 to December 31, 2000 Common stock issued Purchase of equity investment Treasury stock purchased Treasury stock issued in settlement of debt
2000-12-31
2000-03-29 2780.66 未披露
更多>>
from December 31, 1998 to December 31, 1999 Common stock issued Purchase of treasury stock
1999-12-31
1999-03-10 2616.20 未披露
更多>>
from December 31, 1997 to December 31, 1998 Common stock issued Preferred stock converted
1998-12-31
1998-03-27 2104.26 0.37
更多>>
from December 31, 1996 to December 31, 1997 Stock conversion costs Preferred stock redeemed Issuance of preferred stock certificates Preferred stock converted Warrants and options exercised Issuance of common stock, net of issuance cost
1997-12-31
1997-03-25 1616.02 0.50
更多>>
from December 31, 1995 to December 31, 1996 Preferred Stock Issued Preferred Stock Converted Warrants Exercised
1996-12-31
From June 30, 2025 to September 30, 2025 Common stock and warrant issuance, net of costs
Common stock offered 2,000,000 shares by the company
From March 31, 2025 to June 30, 2025 Common stock issuance, net of costs Adjustment for fractional shares
From December 31, 2023 to December 31, 2024 Equity-based compensation Issuance of warrants Repayment of Debt with Shares Common stock issuance, net of costs Cashless exercise of warrants
Securities offered 4,653,036 shares by the company
From June 30, 2024 to September 30, 2024 Common stock issuance, net of costs Equity-based compensation
From March 31, 2024 to June 30, 2024 Common stock issuance, net of costs Series B preferred shares expired
Common stock offered 5,640,958 shares by the company
From December 31, 2023 to March 31, 2024 Common Stock issuance, net of costs Cashless Exercise of Warrants Committed Shares
From December 31, 2022 to December 31, 2023 Common stock issuance, net of costs Series B preferred shares converted to common shares
From June 30, 2023 to September 30, 2023 Common stock issuance, net of costs
From March 31, 2023 to June 30, 2023 Common stock issuance, net of costs Series B preferred shares converted to common shares
From December 31, 2022 to March 31, 2023 Common Stock issuance, net of costs Series B preferred shares converted to common
From December 31, 2021 to December 31, 2022 Common Stock issuance, net of costs Warrant modification
From June 30, 2022 to September 30, 2022 Common stock issuance, net of costs Cashless Warrant Conversion
From March 31, 2022 to June 30, 2022 Series B preferred shares converted to common shares Common stock issuance, net of costs
From December 31, 2020 to December 31, 2021 Series B preferred shares converted to Common shares Shares issued for: Common Stock issuance, net of costs Shares issued to pay accounts payable
From June 30, 2021 to September 30, 2021 Common stock issuances, net of costs
From December 31, 2020 To March 31, 2021 Series B preferred shares converted to common shares Common stock issuances, net of costs
from December 31, 2019 to December 31, 2020 Common Stock issuance, net of costs Shares issued to pay accounts payable Series B preferred shares converted to Common shares
From December 31, 2019 to September 30, 2020 Common stock issuances Shares issued to pay accounts payable Series B preferred shares converted to common shares
From December 31, 2019 to June 30, 2020 Series B preferred shares converted to common shares Shares issued for: Common stock issuances
From December 31, 2019 to March 31, 2020 Series B preferred shares converted to common shares Shares issued for: Common stock issuances Shares issues to pay account payable
From December 31, 2018 to December 31, 2019 Series B preferred shares issued, net of offering costs Series B preferred shares converted to Common shares Shares issued for: Shares sold at the market Common Stock issuance, net of costs Convertible note origination shares Equity-based compensation Shares issues to pay accounts payable
From June 30, 2019 to September 30, 2019 Equity-based compensation Common stock issuance, net of costs Convertible debt Shares issued to pay accounts payable Series B preferred shares converted to common shares
From December 31, 2018 to June 30, 2019 Equity-based compensation Common stock issuance, net of offering costs Convertible debt Shares issued to pay accounts payable Series B preferred shares converted to common shares
As previously disclosed, following stockholder approval of a reverse stock split, the Company’s Board of Directors approved a 1-for-44 reverse stock split of the Company’s issued and outstanding shares of common stock. The Company anticipates that the reverse stock split will be effected on June 10, 2019, and the Company’s common stock will begin trading on a split-adjusted basis on June 11, 2019. The reverse stock split will reduce the number of shares of the Company’s common stock currently outstanding from approximately 96,827,062 shares to approximately 2,200,616 shares.
From December 31, 2018 to March 31, 2019 Common stock issuance, net of costs Series B preferred shares issued, net of costs Series B preferred shares converted to common shares
From December 31, 2017 to December 31, 2018 Shares sold at the market Common stock issuance, net of costs Convertible note origination shares Other issuance Equity-based compensation
From December 31, 2017 to September 30, 2018 Equity-based compensation Common stock issuance, net of costs Common stock issued to settle accounts payable Convertible note origination shares
From December 31, 2017 to June 30, 2018 Equity-based compensation Common stock issuance, net of costs Common stock issued to settle accounts payable
From December 31, 2017 to March 31, 2018 Equity-based compensation Common stock issuance, net of costs Common stock issued to settle accounts payable
from December 31, 2016 to December 31, 2017 Shares issued for: Shares sold at the market Common stock issuance Other issuance Equity-based compensation
From December 31, 2016 To September 30, 2017 Equity-based compensation Common stock issuance, net of costs Common stock issued for accounts payable
from December 31, 2016 to June 30, 2017 Equity-based compensation Common stock issuance, net of costs Stock issued for accounts payable
from December 31, 2016 to March 31, 2017 Equity-based compensation Common stock issuance, net of costs Stock issued for accounts payable
From December 31, 2015 to December 31, 2016 Shares issued for: Shares sold at the market Common stock issuance Other issuance Equity-based compensation Hemispherx Biopharma, announced today that it will effect a 1-for-12 reverse stock split of its common stock.The Company anticipates that the reverse stock split will be effective on August 26, 2016, and the Company's common stock will begin trading on a split-adjusted basis on August 29, 2016.
from December 31, 2015 to September 30, 2016 Equity-based compensation Shares sold at the market Common stock issuance Other issuances Hemispherx Biopharma, announced today that it will effect a 1-for-12 reverse stock split of its common stock.The Company anticipates that the reverse stock split will be effective on August 26, 2016, and the Company's common stock will begin trading on a split-adjusted basis on August 29, 2016.
Hemispherx Biopharma, announced today that it will effect a 1-for-12 reverse stock split of its common stock.The Company anticipates that the reverse stock split will be effective on August 26, 2016, and the Company's common stock will begin trading on a split-adjusted basis on August 29, 2016.
from December 31, 2015 to June 30, 2016 Shares sold at the market
from December 31, 2015 to March 31, 2016 Shares sold at the market
from December 31, 2014 to December 31, 2015 Shares issued for: Settlement of accounts payable Shares sold at the market
from December 31, 2014 to September 30, 2015 Shares to settle accounts payable Shares sold at the market
From December 31, 2014 to June 30, 2015 Shares to settle accounts payable Shares sold at the market
from December 31, 2014 to March 31, 2015 Shares sold at the market
from December 31, 2013 to December 31, 2014 Stock issued for:settlement of accounts payable Stock issued for:Shares sold at the market
from December 31, 2013 to September 30, 2014 Stock issued for settlement of accounts payable Shares sold at the market
from December 31, 2013 to June 30, 2014 Stock issued for settlement of accounts payable Shares sold at the market
from December 31, 2013 to March 31, 2014 Stock issued for settlement of accounts payable Shares sold at the market
From December 31,2012 to December 31,2013 Settlement of accounts payable Shares sold at the market
from December 31, 2012 to September 30, 2013 Stock issued for settlement of accounts payable
from December 31, 2012 to May 1, 2013 Stock issued for settlement of accounts payable
From December 31, 2012 to March 31, 2013 Stock issued for settlement of accounts payable
from December 31, 2011 to December 31, 2012 Shares issued for:Settlement of accounts payable Shares issued for:Shares sold at the market Equity-based compensation
from December 31, 2011 to September 30, 2012 Shares sold at the market Stock issued for settlement of accounts payable Equity-based compensation
from December 31, 2011 to June 30, 2012 Stock issued for settlement of accounts payable Equity-based compensation
from December 31, 2010 to December 31, 2011 Shares issued for:Settlement of accounts payable and accrued expenses Stock-based compensation
from December 31, 2010 to September 30, 2011 Stock issued for settlement of accounts payable Equity based compensation
from December 31, 2010 to June 30, 2011 Stock issued for settlement of accounts payable Equity based compensation
Stock issued for settlement of accounts payable
from December 31, 2009 to December 31, 2010 Shares issued for:Settlement of accounts payable Shares issued for:Shares sold at the market Stock based compensation
from December 31, 2009 to September 30, 2010 Stock issued for settlement of accounts payable Equity based compensation Shares sold at the market
from December 31, 2009 to June 30, 2010 Stock issued for settlement of accounts payable Equity based compensation Shares sold at the market
Stock issued for settlement of accounts payable
from December 31, 2008 to December 31, 2009 Shares issued for:Warrants exercised Shares issued for:Options exercised Shares issued for:Private placement, net of issuance costs Shares issued for:Settlement of accounts payable Stock based compensation
from December 31, 2007 to December 31, 2008 Shares issued for:Private placement, net of issuance costs Shares issued for:Settlement of accounts payable
from December 31, 2006 to December 31, 2007 Shares issued for:Interest on convertible debt Shares issued for:Private placement, net of issuance costs Shares issued for:Stock issued for settlement of accounts payable
from December 31, 2005 to December 31, 2006 Shares issued for:Payment of accounts payable Shares issued for:Conversion of debt Shares issued for:Warrants exercised Shares issued for:Interest in convertible debt Shares issued for:Private placement, net of issuance costs Shares issued for:Purchase patents Shares issued for:Purchase royalty interest
from December 31, 2004 to December 31, 2005 Payment of accounts payable Conversion of debt Interest on convertible debt Private placement, net of issuance costs
from December 31, 2003 to December 31, 2004 Shares issued for:Payment of accounts payable Shares issued for:OID on convertible debt Shares issued for:Purchase of building Shares issued for:Conversion of debt Shares issued for:Interest on convertible debt Shares issued for:Private placement, net of issuance costs Shares issued for:Warrants exercised Stock Issued with convertible debt Treasury shares sold
from December 31, 2002 to December 31, 2003 Debt conversion and interest payments Warrants exercised Common stock issued in connection with ISI acquisition Treasury Stock retired Conversion of minority interest of subsidiary into common stock Stock issued in settlement of debt Treasury stock purchased
from December 31,2001 to December 31,2002 Stock issued in settlement of debt Treasury stock Purchased
from December 31, 2000 to December 31, 2001 Common stock issued Purchase of equity investment Stock issued in settlement of debt Stock and stock warrant compensation expense Treasury stock purchased
from December 31, 1999 to December 31, 2000 Common stock issued Purchase of equity investment Treasury stock purchased Treasury stock issued in settlement of debt
from December 31, 1998 to December 31, 1999 Common stock issued Purchase of treasury stock
from December 31, 1997 to December 31, 1998 Common stock issued Preferred stock converted
from December 31, 1996 to December 31, 1997 Stock conversion costs Preferred stock redeemed Issuance of preferred stock certificates Preferred stock converted Warrants and options exercised Issuance of common stock, net of issuance cost
from December 31, 1995 to December 31, 1996 Preferred Stock Issued Preferred Stock Converted Warrants Exercised